Wheat peptide challenge in coeliac disease

Area of Science:

• Gastroenterology
• Immunology
• Cereal Chemistry

Background:

• Coeliac disease pathogenesis involves reactions to cereal proteins, particularly wheat gliadin.
• Previous in-vitro studies suggested both N-terminal and C-terminal domains of A-gliadin contribute to toxicity.
• The precise allergenic epitopes within gliadin remain incompletely understood.

Purpose of the Study:

• To identify specific wheat A-gliadin peptide sequences responsible for exacerbating coeliac disease.
• To evaluate the in vivo toxicity of synthesized A-gliadin peptides in coeliac disease patients.

Main Methods:

• Synthesis of three A-gliadin peptides (residues 3-21, 31-49, 202-220).
• Intraduodenal challenge of four coeliac disease patients with gliadin or synthetic peptides.
• Analysis of jejunal biopsies for histological changes and intraepithelial lymphocyte counts over 6 hours.

Main Results:

• The synthetic peptide corresponding to A-gliadin amino acids 31-49 induced significant histological damage in the small intestinal mucosa.
• The N-terminal peptide (residues 3-21) showed no toxicity.
• Minor histological changes were observed in one patient with the C-terminal peptide (residues 202-220).

Conclusions:

• The A-gliadin oligopeptide (31-49) is toxic in vivo and likely represents a key epitope in coeliac disease.
• The N-terminal peptide (3-21) is not toxic, while the C-terminal peptide (202-220) shows variable sensitivity.
• Immune activation, potentially via HLA DQ2-restricted T cells, underlies the observed enteropathy.